Dry Eye Relief

Product NDC: 59262-351
11-digit product format: 592620351
Labeler code: 59262
Product ID: 59262-351_9cb069f8-c964-4a76-b161-f457857e6e8a
Type: HUMAN OTC DRUG
Nonproprietary name: Belladonna 6X, Euphrasia 6X, Mercurius sublimatus 6X
Dosage form: SOLUTION/ DROPS
Route: OPHTHALMIC
Labeler: Similasan Corporation
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start: 2013-07-02
Marketing end: 0000-00-00
Substance: ATROPA BELLADONNA; EUPHRASIA STRICTA; MERCURIC CHLORIDE
Active strength: 6 [hp_X]/.4mL; [hp_X]/.4mL; [hp_X]/.4mL
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	59262-351		I	Inactivated by FDA		2026-10-21
excluded package	package	59262-351	59262-351-12	I	Inactivated by FDA		2026-10-21

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 38 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59262-351-12	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59262-351-12	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59262-351-12	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59262-351-12	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59262-351-12	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59262-351-12	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59262-351-12	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59262-351-12	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59262-351-12	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59262-351-12	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59262-351-12	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59262-351-12	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	59262-351-12	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	59262-351-12	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	59262-351-12	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	59262-351-12	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	59262-351-12	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	59262-351-12	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	59262-351-12	`8dfbde2a14a4…`	`c9ff85d89658…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
726062af-1135-4707-a1d7-57256991bbf9	Product name	2	20250226
19c71a3d-ed9c-166b-a7e5-38c250c35631	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
59262-351-12	2021-01-29	C162847	48780-1	ba0f9c33-3018-a910-e053-dadaa90a0b85	Similasan Dry Eye Relief Preservative Free

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
59262-351-12	Dry Eye Relief	20 in 1 CARTON	SOLUTION/ DROPS	20		8
59262-351-12	Dry Eye Relief	0.4 mL in 1 VIAL, SINGLE-USE	SOLUTION/ DROPS	0.4		8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59262-351-12	EA - Each	59262-351	3c95ecd2-cd58-484b-ba8d-7dcc94a4fcb8	1	2022-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ATROPA BELLADONNA	ACTIVE INGREDIENT	WQZ3G9PF0H	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	5
EUPHRASIA STRICTA	ACTIVE INGREDIENT	C9642I91WL	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	5
MERCURIC CHLORIDE	ACTIVE INGREDIENT	53GH7MZT1R	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	5
ATROPA BELLADONNA	ACTIVE MOIETY	WQZ3G9PF0H	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	5
EUPHRASIA STRICTA	ACTIVE MOIETY	C9642I91WL	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	5
MERCURIC CATION	ACTIVE MOIETY	ED30FJ8Y42	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	5
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	22ADO53M6F	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	5
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	INACTIVE INGREDIENT	5QWK665956	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	5
WATER	INACTIVE INGREDIENT	059QF0KO0R	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59262-351	DRY EYE RELIEF (BELLADONNA 6X, EUPHRASIA 6X, MERCURIUS SUBLIMATUS 6X) SOLUTION/ DROPS [SIMILASAN CORPORATION]	8	Legacy NDC, 2 package rows	20190329_f3bad888-2207-4a78-abba-d3c667e30e5c.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
WQZ3G9PF0H	ATROPA BELLADONNA		ATROPA BELLADONNA
C9642I91WL	EUPHRASIA STRICTA		EUPHRASIA STRICTA
53GH7MZT1R	MERCURIC CHLORIDE	7487-94-7	MERCURIC CHLORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
59262-351-12	59262035112	20 in 1 CARTON	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Similasan Dry Eye Relief Preservative Free	Similasan Corporation	2019-03-20	HUMAN OTC DRUG LABEL	8